Published 6 issues per year
ISSN Print: 1045-4403
ISSN Online: 2162-6502
Indexed in
ANP-NPRA Signaling Pathway−A Potential Therapeutic Target for the Treatment of Malignancy
ABSTRACT
It was well established that the atrial natriuretic peptide (ANP)/natriuretic peptide receptor-A (NPRA) signaling pathway controls natriuretic, diuretic, vasorelaxant, and anti-proliferative responses in the regulation of the human cardiovascular system by previous studies. Yet in recent years, more and more evidence has shown that the ANP/NPRA signaling pathway plays an important role in human cancer. For example, NPRA is abundantly expressed on tumorigenic mouse and human prostate cancer (PCa) cells, but not in nontumorigenic prostate epithelial cells and down-regulation of NPRA-induced apoptosis in PCa cells. Dexamethasone can increase the expression of ANP markedly, and that is the reason why dexamethasone is the cornerstone in the treatment of multiple myeloma. NPRA deficiency can substantially protect C57BL/6 mice from lung, skin, and ovarian cancers. These results strongly suggest ANP and NPRA may play an anti-cancer and carcinogenesis role, respectively, and this signaling pathway could be a more potent target for cancer therapy. In light of these new insights, this review will summarize the structures, functions, and their regulation by cell signaling, and their different impacts on tumors.
-
Chen Yang, Li Tianyu, Yu Xiaoqiang, Xu Jianfeng, Li Jianling, Luo Dexiang, Mo Zengnan, Hu Yanling, The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: A pooled analysis of 41 sets of data from case–control studies, Gene, 534, 2, 2014. Crossref
-
Huang Liang-Ti, Chang Hsuen-Wen, Wu Min-Ju, Lai Yong-Tzuo, Wu Wen-Chi, Yu Winston C.Y., Chang Vincent H.S., Klf10 deficiency in mice exacerbates pulmonary inflammation by increasing expression of the proinflammatory molecule NPRA, The International Journal of Biochemistry & Cell Biology, 79, 2016. Crossref
-
Mezzasoma Letizia, Peirce Matthew, Minelli Alba, Bellezza Ilaria, Natriuretic Peptides: The Case of Prostate Cancer, Molecules, 22, 10, 2017. Crossref
-
Santhekadur Prasanna K., Kumar Divya P., Seneshaw Mulugeta, Mirshahi Faridoddin, Sanyal Arun J., The multifaceted role of natriuretic peptides in metabolic syndrome, Biomedicine & Pharmacotherapy, 92, 2017. Crossref